These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 742041)

  • 21. Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemia.
    Gore SD; Weng LJ; Jones RJ; Cowan K; Zilcha M; Piantadosi S; Burke PJ
    Clin Cancer Res; 1995 Mar; 1(3):295-303. PubMed ID: 9815985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacterial proteins as potential drugs in the treatment of leukemia.
    Kwan JM; Fialho AM; Kundu M; Thomas J; Hong CS; Das Gupta TK; Chakrabarty AM
    Leuk Res; 2009 Oct; 33(10):1392-9. PubMed ID: 19250673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth suppression of human leukemic cells in vitro by L-ascorbic acid.
    Park CH; Amare M; Savin MA; Hoogstraten B
    Cancer Res; 1980 Apr; 40(4):1062-5. PubMed ID: 6928398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Significance of cellular kinetics in relation to chemotherapy of human leukemias].
    Alberto P
    Schweiz Med Wochenschr; 1971 Oct; 101(42):1510-5. PubMed ID: 5143015
    [No Abstract]   [Full Text] [Related]  

  • 25. Cytoenzymochemical changes in acute leukemia cells under cytostatic treatment.
    Rădulescu E
    Morphol Embryol (Bucur); 1984; 30(3):205-10. PubMed ID: 6239098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antibody therapy in hematology and oncology--2].
    Kneba M; Schrader C; Köhne H
    Med Klin (Munich); 2009 Jan; 104(1):28-49. PubMed ID: 19142594
    [No Abstract]   [Full Text] [Related]  

  • 27. [Determination of the sensitivity of leukemic blasts to cytostatic agents by means of an isotope method].
    Kuliszkiewicz-Janus M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):213-7. PubMed ID: 6168529
    [No Abstract]   [Full Text] [Related]  

  • 28. Sensitivity of normal and neoplastic cells to chemotherapeutic agents in vitro.
    Dow LW
    Adv Intern Med; 1980; 25():427-52. PubMed ID: 6987848
    [No Abstract]   [Full Text] [Related]  

  • 29. The anti-leukemic efficacy of the third generation bisphosphonate ONO5920/YM529.
    Segawa H; Kimura S; Kuroda J; Sato K; Nogawa M; Yuasa T; Yokota A; Hodohara K; Fujiyama Y; Maekawa T
    Leuk Res; 2005 Apr; 29(4):451-7. PubMed ID: 15725480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The stochastic blueness of leukemic stem cells in experimental antineoplastic therapy.
    Janković GM; Colović MO; Petrović MO; Rolović ZN; Janosević S
    Exp Hematol; 1993 Oct; 21(11):1399-400. PubMed ID: 8405217
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of stabilized human cell lines derived from hematopoietic cells as models for testing cytostatics].
    Koubek K; Bumbrlová R; Bartos F; Chudomel V; Stöckbauer P; Procházková J
    Cesk Farm; 1984 Jul; 33(6):238-43. PubMed ID: 6498958
    [No Abstract]   [Full Text] [Related]  

  • 32. Antiproliferative effects of lipoxygenase inhibitors on human leukemia cells.
    Snyder DS
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():921-4. PubMed ID: 1825435
    [No Abstract]   [Full Text] [Related]  

  • 33. [Methods of studying antimitotic products].
    Maral R
    Biol Med (1971); 1973 Dec; 2(2):97-122. PubMed ID: 4620253
    [No Abstract]   [Full Text] [Related]  

  • 34. [A preliminary report of a quick method for determining drug sensitivity of leukemic cells in vitro (author's transl)].
    Da WM
    Zhonghua Nei Ke Za Zhi; 1982 Feb; 21(2):109-12. PubMed ID: 7094702
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of an 'in vitro' sensitivity test for human leukemic cells.
    Bhisey AN; Kavi BR; Gollerkeri MP; Ranadive KJ
    Indian J Cancer; 1975 Sep; 12(3):302-9. PubMed ID: 1193662
    [No Abstract]   [Full Text] [Related]  

  • 36. [A study on proliferation kinetics of human leukemic blast cells and application in treatment of acute non-lymphocytic leukemia by the use of flow cytometry (author's transl)].
    Tsubaki K; Iwanaga T; Irimajiri K; Horiuchi A
    Rinsho Ketsueki; 1981 Dec; 22(12):1916-22. PubMed ID: 7345179
    [No Abstract]   [Full Text] [Related]  

  • 37. The heterogeneous proliferation of human cancer cells in vivo.
    Post J; Sklarew RJ
    Pathol Annu; 1985; 20 Pt 1():359-81. PubMed ID: 3887298
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of dose interval on the survival of L1210 leukemic mice treated with DNA synthesis inhibitors.
    Neil GL; Homan ER
    Cancer Res; 1973 Apr; 33(4):895-901. PubMed ID: 4696483
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of cancer chemotherapeutic agents on induction of differentiation of cells and their therapeutic implications].
    Hozumi M
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):714-20. PubMed ID: 3457551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of neoplasms of the hematopoietic system based on some principles of cytokinetics].
    Traczyk Z
    Acta Haematol Pol; 1974; 5(1):85-90. PubMed ID: 4595062
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.